Iradimed (IRMD) EBIT Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 703.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 703.00 |
| Dec 31, 2025 | -8,634.00 |
| Sep 30, 2025 | 141.00 |
| Jun 30, 2025 | 51.00 |
| Mar 31, 2025 | 286.00 |
| Dec 31, 2024 | 373.00 |
| Sep 30, 2024 | 329.00 |
| Jun 30, 2024 | 1,259.00 |
| Mar 31, 2024 | 772.00 |
| Dec 31, 2023 | 2,195.00 |
| Sep 30, 2023 | 2,559.00 |
| Jun 30, 2023 | 7,388.00 |
| Mar 31, 2023 | 1,740.00 |
| Dec 31, 2022 | 806.00 |
| Sep 30, 2022 | 554.00 |
| Jun 30, 2022 | 700.00 |
| Mar 31, 2022 | 704.00 |
| Dec 31, 2021 | 469.00 |
| Sep 30, 2021 | 928.00 |
| Jun 30, 2021 | -391.00 |
| Mar 31, 2021 | 397.00 |
| Dec 31, 2020 | -729.00 |
| Sep 30, 2020 | 675.00 |
| Jun 30, 2020 | -4,904.00 |
| Mar 31, 2020 | 1,311.00 |
| Dec 31, 2019 | -457.00 |
| Sep 30, 2019 | -852.00 |
| Jun 30, 2019 | -809.00 |
| Mar 31, 2019 | -2,089.00 |
| Dec 31, 2018 | -1,660.00 |
| Sep 30, 2018 | -2,007.00 |
| Jun 30, 2018 | -1,269.00 |
| Mar 31, 2018 | -1,709.00 |
| Dec 31, 2017 | 862.00 |
| Sep 30, 2017 | -721.00 |
| Jun 30, 2017 | -2,833.00 |
| Mar 31, 2017 | -2,778.00 |
| Dec 31, 2016 | 422.00 |
| Sep 30, 2016 | 1,945.00 |
| Jun 30, 2016 | 575.00 |